Home/Filings/4/0001415889-25-018643
4//SEC Filing

Duncan Gregory Scott 4

Accession 0001415889-25-018643

CIK 0001818844other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 2:00 PM ET

Size

5.5 KB

Accession

0001415889-25-018643

Insider Transaction Report

Form 4
Period: 2025-06-27
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2025-06-27+40,00040,000 total
    Exercise: $4.71Exp: 2035-06-27Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The stock option vests one-third on June 27, 2026 and 1/24th monthly thereafter.

Issuer

Dogwood Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1
  • filerCIK 0001831127

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 2:00 PM ET
Size
5.5 KB